U-Vend, Inc. Reports Second Quarter 2017 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
124
U-Vend, Inc. Reports Second Quarter 2017 Financial Results

SANTA MONICA, CA--(Marketwired - Aug 17, 2017) - U-Vend, Inc. ( OTCQB : UVND ) (the "Company"), a consumer products and technology company that develops, distributes, and markets next-generation self-serve electronic kiosks and merchandisers with a digital advertising component across North America, this week announced its financial results for the second quarter ended June 30, 2017.

"Our revenue continues to grow as we remain committed to expanding the points-of-sale for our Mini Melts product. In the past three months, we have secured an additional 60 sites for our very popular 'Grab-N-Go' merchandisers, giving U-Vend a total of 245 retail locations in our Southern California and Las Vegas markets," stated David Graber, U-Vend, Inc. CEO. "In addition, we continue to focus on our professional sports ice cream product line, with an anticipated production and launch into retail stores during the second half of 2017," added Graber.

Select Financial Data for Three and Six Months Ended June 30, 2017

  • Revenues for the three months ended June 30, 2017 increased 15.6% to $441,156 as compared to revenue of $381,481 for the three months ended June 30, 2016.
  • Gross profits for the second quarter 2017 increased 8.4% to $219,691 as compared to gross profit of $202,607 for the second quarter of 2016.
  • Gross margins for the quarter ended June 30, 2017 were approximately 50% as compared to gross margin of 53% for the quarter ended June 30, 2016.
  • Net loss for the second quarter of 2017 was $666,409 as compared to a net loss of $569,869 for the second quarter of 2016.
  • Basic and diluted net loss per share of ($0.03) per common share for the three months ended June 30, 2017 equaled the ($0.03) net loss per common share for the three months ended June 30, 2016.
  • Revenues for the six months ended June 30, 2017 increased 14.2% to $771,182 as compared to revenue of $675,023 for the six months ended June 30, 2016.
  • Gross profits for the six months ended June 30, 2017 increased 8% to $380,826 as compared to gross profit of $352,533 for the six months ended June 30, 2016.
  • Gross margins for the six months ended June 30, 2017 were approximately 50% as compared to gross margin of 52% for the six months ended June 30, 2016.
  • Net loss for the six months ended June 30, 2017 was $1,297,370 as compared to a net loss of $1,058,350 for the six months ended June 30, 2016.
  • Basic and diluted net loss per share of per common share for the six months ended June 30, 2017 was ($0.05) vs. ($0.06) basic and diluted net loss per common share for the six months ended June 30, 2016.

A full analysis of results for the quarter and six months ended June 30, 2017 is available in the Company's Form 10-K, which is available on the Company's website at www.u-vend.com or through the Securities and Exchange Commission's Edgar database at www.sec.gov .

ABOUT U-VEND, INC. U-Vend, Inc., headquartered in Santa Monica, CA, and with offices in Orange, CA and Las Vegas, NV, is a consumer products and automated retailing company specializing in the creation, marketing and sales of unique ice cream and related food products which are distributed to the retail markets utilizing various "next-generation" self-serve electronic kiosks throughout North America. The Company owns and operates kiosks and has partnered with numerous national consumer product companies to deliver new and innovative customer retail experiences in automated "frictionless" settings. For more information on U-Vend, visit www.u-vend.com or call (855) 55-UVEND.

Follow U-Vend on Twitter and Like U-Vend on Facebook  

FORWARD LOOKING STATEMENTS Certain statements contained in this news release regarding matters that are not historical facts may be forward-looking statements. Because such forward-looking statements include risks and uncertainties, actual results may differ materially from those expressed in or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties pertaining to market acceptance for the Company's products and services, its ability to succeed in increasing revenues in the near term to attain profitable operations and generate sufficient cash flow from operations, the effect of new competitors in its markets, its integration of acquired businesses, and other risk factors identified from time to time in its filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and current reports on Form 8-K which are available at the SEC's website www.sec.gov . Other factors not currently anticipated may also materially and adversely affect U-Vend's results of operations, financial position, and cash flows. There can be no assurance that future results will meet expectations. While the Company believes that the forward-looking statements in this news release are reasonable, the reader should not place undue reliance on any forward-looking statement. In addition, these statements speak only as of the date made. The Company does not undertake, and expressly disclaims any obligation to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

For more information, contact: U-Vend, Inc. Corporate Office Tel: (855) 55-UVEND Email: Email Contact U-Vend, Inc. Sales & Marketing Tel: (855) 55-UVEND, ext. 4 Email: Email Contact U-Vend, Inc. Investor Relations Tel: (855) 55-UVEND, ext. 3 Email: Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 509

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 0

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 523

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 441

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Thames Ventures VCT 1 PLC Reports Unaudited NAV for 2024

Updated Category News Views 81

Thames Ventures VCT 1 PLC Releases Unaudited NAV for 2024 Thames Ventures VCT 1 PLC has provided important updates about its financial status through its unaudited net asset value (NAV). As of June 30, 2024, the NAV stands at 45.9p per share. This announcement is significant for both the company and its investors, as understanding the NAV is essential for evaluating the...

Continue Reading
Gap Inc Achieves Impressive Growth and Market Expansion

Updated Category News Views 362

Gap Inc Reports Promising Financial Results Shares of Gap Inc (GAP) saw a significant uptick in early trading on Friday following the announcement of their latest quarterly results. This positive financial report highlighted a stronger performance than expected, showcasing the company's effective strategies and management efforts. Analysts' Positive Outlook on Gap In the...

Continue Reading
The Town Lake Company's Bold New Industrial Project Launch

Updated Category News Views 226

The Town Lake Company Initiates New Industrial Development Benchmark Business Parks, a division of The Town Lake Company, has proudly initiated construction on its latest small-bay industrial project. This significant development is located at 1433 Chris Lane and will encompass an impressive 84,200 square feet of innovative tilt-wall flex industrial space. The project is...

Continue Reading
Investors Unite in Class Action Against Everus Construction Group

Updated Category News Views 330

Opportunity for Investors in Everus Construction Group, Inc. In recent developments, investors of Everus Construction Group, Inc. (NYSE: ECG) have found themselves in the midst of a class action lawsuit that has drawn considerable attention. This lawsuit targets purchases made by investors during a specified period, raising important questions about the company's...

Continue Reading
Lam Research Board Approves Quarterly Dividend Announcement

Updated Category News Views 120

Lam Research Corporation Declares New Dividend Lam Research Corporation (Nasdaq: LRCX) has recently made an important announcement regarding its financial strategy. In their latest meeting, the company's Board of Directors approved a quarterly dividend of $0.23 per share for all common stockholders. This decision reflects Lam Research's commitment to providing value to...

Continue Reading